Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2009
Headcount
6
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Ullman Medical has identified and developed a novel botanical extract that demonstrated positive human clinical data in treating psoriasis. Pre-clinical evidence also showed non-toxic, anti-angiogenesis properties that may be effective in the treatment of eye diseases, arthritis, and certain cancers. The companys objective is the commercialization of this plant-based compound for the topical treatment of psoriasis and development of a therapeutic platform for the treatment of numerous immune-deficient diseases. Psoriasis remains a chronic skin disease with few safe, effective topical treatments.
Q&A
- What is Ullman Medical's primary focus?
- Ullman Medical focuses on plant-based psoriasis therapy, developing a novel botanical extract for topical treatment of psoriasis and a therapeutic platform for immune-deficient diseases.
- What is the current status of Ullman Medical?
- Ullman Medical is currently inactive, having ceased operations in March 2019.
- Where is Ullman Medical headquartered?
- Ullman Medical is headquartered in Petah Tikva, Center District, Israel.
- When was Ullman Medical founded?
- Ullman Medical was founded in January 2009.
- What is Ullman Medical's employee count?
- Ullman Medical has an employee count in the 1-10 range.
- What stage is Ullman Medical's product in?
- Ullman Medical's product is in the clinical trial stage.
- Who is a key team member at Ullman Medical?
- Pircha Lottner serves as the President & Chairman at Ullman Medical.
- What are the potential additional applications of Ullman Medical's botanical extract?
- Pre-clinical evidence suggests the botanical extract may also be effective in treating eye diseases, arthritis, and certain cancers due to its non-toxic, anti-angiogenesis properties.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Tags
stealthmodebiotechnologyeye-diseasespharmaceuticalspatent-pendingdermatologytreatmentscancertopical-treatment
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2009-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Mar 2019 ceased to operate |